NON-PEPTIDIC CCR1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PROGRESSIVE KIDNEY FIBROSIS

摘要

This invention is directed to pharmaceutical compositions useful in treating progressive renal fibrosis in mammals comprising a pharmaceutically acceptable excipient and a therapeutically effective amount of a non-peptide CCR1 receptor antagonist.